Hydrogenation of imines with RU complexes
US-12441700-B2 · Oct 14, 2025 · US
US2024300972A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024300972-A1 |
| Application number | US-202418617043-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 26, 2024 |
| Priority date | Sep 27, 2021 |
| Publication date | Sep 12, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are compounds according to Formula A wherein the compound comprises at least one C 6-30 aliphatic moiety. Also disclosed are compositions comprising the compounds that may be useful for delivering agents such as therapeutic and/or prophylactic agents, for example, nucleic acids such as, but not limited to, DNA or RNA, small molecules, proteins, polypeptides or peptides. In some embodiments, the composition is a lipid nanoparticle. Also disclosed herein are lipid nanoparticles comprising the compounds and methods for making and using the nanoparticles.
Opening claim text (preview).
We claim: 1 . A compound according to Formula A wherein: X is a bond, —C(O)O—, —OC(O)—, —NH—, —N(R 1 )—, —C(O)N(R 1 )—, —N(R 1 )C(O)—, —C(O)NH—, —NHC(O)—, —C≡C—, —CH═CH—, —O—, —S—, —NHC(O)NH—, —OC(O)O—, —OC(O)NH—, —NHC(O)O—, —O(CH 2 ) m or —(CH 2 ) m O—; m is from 0 to 6; each R 1 is H, halogen, CN, or aliphatic; R 2 is H, halogen, aromatic, or aliphatic; or X is a bond and R 1 and R 2 , together with the atoms to which there are attached, form a 4- to 7-membered nitrogen-containing non-aromatic heterocyclyl; R A3 is halogen, R 3 , —C(O)N(R 6 )(R 7 ), —C(O)R 3 , —CN, —(CH 2 ) r N(R 6 )(R 7 ), —N(R 6 )(R 7 ), —S(O)R d , —S(O)R 3 , —CH 2 SR d , —CH 2 R 3 , —S(O)N(R 6 )(R 7 ), or —X 1 (CH 2 ) r N(R a ) 2 ; X 1 is O, S or NH; r is from 1 to 8; each R a independently is H, C 1-6 alkyl, C 3-6 cycloalkyl, or both R a s together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclyl; R 3 is aliphatic, —O-aliphatic or N(R 6 )(R 7 ); R A4 is halogen, boronic acid, —N(R 4 )(R 5 ), NHC(O)N(R 4 )(R 5 ), —N═CHR d , —NHC(S)N(R 4 )(R 5 ), —NHC(O)(CH 2 ) z —N(R 4 )(R 5 ), —NHSO 2 R d , —NHS(O)R d , —NHC(O)C(O)NH(CH 2 ) z —N(R 4 )(R 5 ), or —OR 4 , where z is an integer from 1 to 6; each R d is aliphatic; R 4 is aliphatic or —C(O)aliphatic; R 5 is H, aliphatic, or —C(O)aliphatic; R 6 is H or aliphatic; R 7 is aliphatic or C(O)aliphatic; or R 6 and R 7 , together with the atom to which there are attached, form a 4- to 7-membered nitrogen-containing heterocyclyl; and wherein the compound comprises at least one C 6-30 aliphatic moiety. 2 . The compound of claim 1 , wherein: R 6 is H or aliphatic; and R 7 is aliphatic or C(O)aliphatic. 3 . The compound of claim 1 , having a Formula I: wherein X is a bond, —NH—, —N(R 1 )—, or —OC(O)—. 4 . The compound of claim 1 , having a Formula I-A: 5 . The compound of claim 4 , wherein R 1 is aliphatic; R 2 is H or aliphatic; or R 1 and R 2 , together with the atoms to which there are attached, form a 5- to 7-membered nitrogen-containing non-aromatic heterocyclyl; R 3 is aliphatic, —O-aliphatic or N(R 6 )(R 7 ); R 4 is aliphatic or —C(O)aliphatic; R 5 is H, aliphatic or —C(O)aliphatic; R 6 is H or aliphatic; R 7 is aliphatic or C(O)aliphatic; and wherein the compound comprises at least one C 6-30 aliphatic moiety. 6 . The compound of claim 1 , wherein R 1 is C 6-30 aliphatic. 7 . The compound of claim 1 , wherein R 1 is C 6-10 aliphatic. 8 . The compound of claim 1 , wherein R 1 is C 1-6 alkyl and is substituted with N(R a ) 2 , where each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl. 9 . The compound of claim 8 , wherein R 1 is —(CH 2 ) 14 N(R a ) 2 . 10 . The compound of claim 9 , wherein R 1 is —CH 2 NH 2 . 11 . The compound of claim 1 , wherein R 2 is H. 12 . The compound of claim 1 , wherein R 2 is C 6-30 aliphatic. 13 . The compound of claim 1 , wherein R 1 and R 2 are both C 6-30 aliphatic, and R 1 and R 2 are different. 14 . The compound of claim 1 , wherein the compound has a formula wherein each of R 1 and R 2 independently is C 6-30 aliphatic. 15 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 16 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 17 . The compound of claim 1 , wherein the compound has a formula wherein: each of R 1 and R 2 independently is C 6-30 aliphatic; and each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl. 18 . The compound of claim 17 , wherein the compound has a formula 19 . The compound of claim 1 , wherein the compound has a formula wherein: each R a independently is H or C 1-6 alkyl, or both R a s together with the nitrogen to which they are attached form an optionally substituted 5- or 6-membered heterocyclyl; and s is an integer from 1 to 8. 20 . The compound of claim 19 , wherein the compound has a formula 21 . The compound of claim 15 , wherein s is an integer from 1, 2, 3 or 4. 22 . The compound of claim 8 , wherein each R a independently is C 1-6 alkyl. 23 . The compound of claim 16 , wherein: s is 2 or 3; each of R 1 and R 2 independently is C 6-10 alkyl; R 3 is O-methyl or O-ethyl; each R a independently is C 14 alkyl; or a combination thereof. 24 . The compound of claim 1 , wherein X is a bond and R 1 and R 2 , together with the atoms to which there are attached, form a 4- to 7-membered nitrogen-containing non-aromatic heterocyclyl; provided that the compound is not of the formula: or a salt thereof. 25 . The compound of claim 24 , wherein the compound has a formula II′: wherein: R 8 is H or R c ; and R c is -aliphatic, -aliphatic-amino, —C(O)-aliphatic, or —C(O)-aliphatic-amino. 26 . The compound of claim 24 , wherein the compound has a formula II: wherein: R 8 is H or Re; and R c is -aliphatic, -aliphatic-amino, —C(O)-aliphatic, or —C(O)-aliphatic-amino. 27 . The compound of claim 26 , wherein the compound has a formula II-a: 28 . The compound of claim 25 , wherein R
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine · CPC title
having five-membered rings · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.